semaglutide gastric intestinal obstruction lawsuit in louisiana kentucky glp-1 attorney semaglutide diarrhea law firm kentucky semaglutide gastrointestinal obstruction lawyer Wegovy® kentucky glp-1 gastrointestinal obstruction law – semaglutide gastric intestinal obstruction legal

According to the company, certain FDA-approved GLP-1/GIP medications may be eligible for insurance coverage, and the company states it assists with prior authorizations but does not bill insurance directly

September 1, 2025: FDA Approves Wegovy for Fatty Liver Disease The FDA has granted a new indication for Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease in adults with moderate to advanced fibrosis

In other words, it is possible for patients to maintain weight while stopping the medication but some patients may also gain weight at a faster rate or a greater degree than what is seen in the scientific studies, says Lofton

A further 979 patients were overweight or obese, with 361 prescribed semaglutide

Injectable forms tend to be more expensive, especially at higher doses